Maverick Capital’s Halozyme HALO Stock Holding History

Maverick Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,711	Closed	-$113K	–	755
2021 Q1	$113K	Sell	2,711 -12,453	-82%	-$569K	﹤0.01%	572
2020 Q4	$648K	Buy	+15,164	New	+$545K	0.01%	316

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital's HALO Position: Q2 2021 in Review

Maverick Capital sold out of Halozyme (HALO) in Q2 2021, closing a stake of 2,711 shares — an estimated $113K sold.

Maverick Capital first reported a position in HALO in Q4 2020 and held it in 2 quarters. The position peaked at $648K in Q4 2020. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

Maverick Capital reported no remaining Halozyme position as of Q2 2021 after selling out during the quarter.
Maverick Capital sold 2,711 Halozyme shares in Q2 2021, an estimated $113K.
Maverick Capital first reported a position in Halozyme in Q4 2020 and held it in 2 quarters.
Maverick Capital's Halozyme position peaked at $648K in Q4 2020.
313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on Maverick Capital's 13F filing for Q2 2021, filed 16 Aug 2021.